| MSC | Mesenchymal stem cells |
| ECM | Extracellular matrix |
| TNF-α | Tumor necrosis factor alpha |
| IL-1 | Interleukin-1 |
| PD-1 | Programmed death 1 |
| PD-L1 | Programmed cell death 1 ligand 1 |
| PD-L2 | Programmed cell death 1 ligand 2 |
| TGF-β | Transforming growth factor-β |
| Tregs | Regulatory T cells |
| TSG-6 | TNF-α-stimulated gene/protein 6 |
| CXCL8 | C-X-C motif chemokine ligand 8 |
| PMNs | Polymorphonuclear neutrophils |
| CCL2 | Chemokine ligand-2 |
| IL-6 | Interleukin-6 |
| CXCL12 | C-X-C motif chemokine ligand 12 |
| CXCR4 | C-X-C motif chemokine receptor 4 |
| BMP-2 | Bone morphogenetic protein 2 |
| ASCs | Adipose-derived stem cells |
| PSCs | Pericytes |
| IFNγ | Interferon gamma |
| iNOS | Inducible nitric oxide synthase |
| GVHD | Graft-versus-host disease |
| NO | Nitric oxide |
| IL-17A | Interleukin 17A |
| AUF1 | ARE-binding protein ARE/poly(U)-binding/degradation factor 1 |
| NFκB | Nuclear Factor Kappa B |
| TNFR1 | Tumor necrosis factor-alpha receptor 1 |
| RANKL | Receptor activator of nuclear factor kappa-B ligand |
| COX-2 | Cyclooxygenase-2 |
| PGE2 | Prostaglandin E2 |
| IL-10 | Interleukin 10 |
| LPS | Lipopolysaccharide |
| IDO | Indoleamine 2,3-dioxygenase |
| BM-MSCs | Bone marrow-derived mesenchymal stem cells |
| VEGF | Vascular endothelial growth factor |
| HO-1 | Heme oxygenase-1 |
| EVs | Extracellular vesicles |
| MSC-Des | Mesenchymal stem cell-derived exosomes |
| CM | Conditioned Medium |
| LD | linear dichroism |
| miRNA | Micro RNA |
| OI | Osteogenesis imperfecta |
| C-RP | C-reactive protein |
| ESR | Erytrocyte sedimentation rate |